Search Login Register

Iridocyclitis Summary

304 relevant articles (11 outcomes, 16 trials/studies) found for this Disease

Description: Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.

Also Known As: Cyclitides, Heterochromic; Heterochromic Cyclitides; Iridocyclitides; Cyclitis, Heterochromic; Heterochromic Cyclitis

Key Drugs and Agents for Iridocyclitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antinuclear Antibodies : 1 outcome 3 studies in 26 results : IBA
  2. Adrenal Cortex Hormones (Corticosteroids) : 1 outcome 1 study in 12 results : IBA
  3. Retinaldehyde (Retinal) : 1 outcome in 21 results : IBA
  4. Fibrin : 1 outcome in 3 results : IBA
  5. Triamcinolone Acetonide (Azmacort) : 1 outcome in 2 results : FDA 131 Generic
  6. Mechlorethamine (Nitrogen Mustard) : 1 outcome in 2 results : FDA 1
  7. Ivermectin (Mectizan) : 1 outcome in 2 results : FDA 1
  8. Bromocriptine (Parlodel) : 1 outcome in 2 results : FDA 5 Generic
  9. HLA-Bw51 : 1 outcome in 2 results : IBA
  10. Tissue Plasminogen Activator (Alteplase) : 1 outcome in 1 result : FDA 2
Show All >>

Diseases Related to Iridocyclitis

  1. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
  2. Arthritis (Polyarthritis)
  3. Keratitis
  4. Uveitis
  5. Cataract (Cataracts)
Show All >>

Key Therapies for Iridocyclitis

Efficacy Chart >>
  1. Cataract Extraction : 1 outcome in 24 results
  2. Drug Therapy (Chemotherapy) : 1 outcome in 3 results
  3. Plasma Exchange : 1 outcome in 1 result
  4. Investigational Therapies (Experimental Therapy) : 1 study in 1 result
  5. Corneal Transplantation (Keratoplasty) : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.